연구성과로 돌아가기

2024 연구성과별 연구자 정보 (727 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN de laffolie, J. de Laffolie, J 16 Justus Liebig Univ Giessen, Gen Pediat & Pediat Gastroenterol, Giessen, Germany
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Miele, E. Miele, E 17 Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Bramuzzo, M. Bramuzzo, M 18 IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Olen, O. Olén, O 19 Karolinska Inst, Dept Med Sona, Div Clin Epidemiol, Stockholm, Sweden 0000-0002-5478-7019 Olen, Ola
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Olen, O. Olén, O 19 Sachs Childrens Hosp, Pediat Gastroenterol & Nutr Unit, Stockholm, Sweden 0000-0002-5478-7019 Olen, Ola
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Russell, R. Russell, R 20 Royal Hosp Children & Young People, Dept Paediat Gastroenterol Hepatol & Nutr, Edinburgh, Midlothian, Scotland
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Rohani, P. Rohani, P 21 Univ Tehran Med Sci, Pediat Ctr Excellence, Childrens Med Ctr, Pediat Gastroenterol & Hepatol Res Ctr, Tehran, Iran
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Tzivinikos, C. Tzivinikos, C 22 Mohammed Bin Rashid Univ, Al Jalila Childrens Specialty Hosp, Dubai Med Coll, Paediat Gastroenterol Dept, Dubai, U Arab Emirates
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Urlep, D. Urlep, D 23 Univ Med Ctr Ljubljana, Childrens Hosp, Dept Gastroenterol Hepatol & Nutr, Ljubljana, Slovenia
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN van Rheenen, P. van Rheenen, P 24 Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Gastroenterol, Groningen, Netherlands
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN de Ridder, L. de Ridder, L 25 Erasmus MC, Sophia Childrens Hosp, Dept Paediat Gastroenterol, Rotterdam, Netherlands
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Yogev, D. Yogev, D 26 Shaare Zedek Med Ctr, Juliet Keidan Inst Pediat Gastroenterol & Nutr, Jerusalem, Israel
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Yogev, D. Yogev, D 26 Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Schneider, A. M. Schneider, AM 27 Paracelsus Med Univ, Dept Pediat, Salzburg, Austria
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Cohen, S. Cohen, S 28 Tel Aviv Univ, Fac Med, Tel Aviv, Israel
페이지 이동: